OpenAI is bragging that its forthcoming models are so advanced, they may be capable of building brand-new bioweapons. In a recent blog post, the company said that even as it builds more and more ...

The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.

TORONTO: Scientists have created an energy efficient model biological supercomputer that can process information very quickly and accurately using parallel networks in the same way that massive ...

Accurate cancer models are integral to the success of preclinical research yet have proven elusive. Mindy Goldsborough (ATCC, VA, USA) discusses the ongoing efforts to develop improved in vitro models ...